So it looks like this drop was based on the flawed assumption that TLX591 is a flop because of only a moderate decrease in PSA levels although this was seen in a previous trial which showed extremely high comparative efficacy to competing drugs.
Most of us were confused about whether it was the trial result or the 4c which was the root cause, although the 4c looked pretty good to me.
Definitely looks like the trial was the main offender so by rights when the market realises it's written off TLX591 for no good reason we should quickly head back towards $11.
I'll be freeing up some cash to get some more down here.
TLX Chart, page-1199
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.13 |
Change
-0.340(1.75%) |
Mkt cap ! $6.401B | |||
| Open | High | Low | Value | Volume |
| $19.41 | $19.46 | $18.81 | $121.0M | 6.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7316 | $19.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.13 | 6814 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |